Dexmedetomidine preconditioning reduces ischaemia-reperfusion injury in equine model of large colon volvulus.
Authors: Watkins Amanda, Engiles Julie, Long Alicia, Brandly Jerrianne, Hopster Klaus
Journal: Equine veterinary journal
Summary
# Editorial Summary Large colon volvulus carries devastating consequences in equine practice, with tissue damage occurring not only during the initial blood flow obstruction but critically during the reperfusion phase once the volvulus is corrected—a phenomenon known as ischaemia-reperfusion (IR) injury. Watkins and colleagues investigated whether dexmedetomidine, an alpha-2 agonist commonly used in equine anaesthesia, could protect colonic tissue when administered as a constant rate infusion prior to IR injury, using an experimental model that occluded venous, arterial and transmural blood supply to a section of large colon for 3 hours followed by 3 hours of reperfusion. Horses receiving dexmedetomidine demonstrated significantly better histological outcomes: crypt epithelial loss was reduced (median score 2.1 vs 3.1 on a 0–4 scale), mucosal haemorrhage decreased (2.1 vs 3.5), crypt length remained longer (369.5 µm vs 238.5 µm), and tissue oedema was less severe as indicated by a lower interstitium-to-crypt ratio (1.4 vs 2.6). Whilst the clinical utility of preconditioning before colic surgery is limited, the authors emphasise that investigating dexmedetomidine's protective effects when administered *after* volvulus correction—termed postconditioning—may represent a genuinely applicable intervention to mitigate reperfusion damage in clinical cases.
Read the full abstract on PubMed
Practical Takeaways
- •Dexmedetomidine given as a preconditioning agent before large colon volvulus surgery may offer histologic protection against ischaemia-reperfusion damage and reduce mucosal injury
- •While promising in this controlled experimental model, clinical applicability is limited; results suggest investigating postconditioning protocols may be more feasible for field colic cases
- •This research supports further investigation of dexmedetomidine as a therapeutic intervention in suspected large colon volvulus cases, though clinical trials in actual colic cases are needed
Key Findings
- •Dexmedetomidine preconditioning reduced crypt epithelial loss severity (DEX 2.1 vs CON 3.1, p=0.03) compared to saline control
- •Mucosal haemorrhage was decreased in dexmedetomidine group (DEX 2.1 vs CON 3.5, p=0.03)
- •Crypt length remained significantly longer in dexmedetomidine group during reperfusion (369.5±91.7 μm vs 238.5±72.6 μm, p=0.02)
- •Interstitium to crypt ratio was lower in dexmedetomidine group (DEX 1.4 vs CON 2.6, p=0.03), indicating less mucosal oedema